CMV immune evasion and manipulation of the immune system with aging

Sarah E. Jackson, Anke Redeker, Ramon Arens, Debbie van Baarle, Sara P.H. van den Berg, Chris A. Benedict, Luka Čičin-Šain, Ann B. Hill, Mark R. Wills

Research output: Contribution to journalReview article

31 Scopus citations

Abstract

Human cytomegalovirus (HCMV) encodes numerous proteins and microRNAs that function to evade the immune response and allow the virus to replicate and disseminate in the face of a competent innate and acquired immune system. The establishment of a latent infection by CMV, which if completely quiescent at the level of viral gene expression would represent an ultimate in immune evasion strategies, is not sufficient for lifelong persistence and dissemination of the virus. CMV needs to reactivate and replicate in a lytic cycle of infection in order to disseminate further, which occurs in the face of a fully primed secondary immune response. Without reactivation, latency itself would be redundant for the virus. It is also becoming clear that latency is not a totally quiescent state, but is characterized by limited viral gene expression. Therefore, the virus also needs immune evasion strategies during latency. An effective immune response to CMV is required or viral replication will cause morbidity and ultimately mortality in the host. There is clearly a complex balance between virus immune evasion and host immune recognition over a lifetime. This poses the important question of whether long-term evasion or manipulation of the immune response driven by CMV is detrimental to health. In this meeting report, three groups used the murine model of CMV (MCMV) to examine if the contribution of the virus to immune senescence is set by the (i) initial viral inoculum, (ii) inflation of T cell responses, (iii) or the balance between functionally distinct effector CD4+ T cells. The work of other groups studying the CMV response in humans is discussed. Their work asks whether the ability to make immune responses to new antigens is compromised by (i) age and HCMV carriage, (ii) long-term exposure to HCMV giving rise to an overall immunosuppressive environment and increased levels of latent virus, or (iii) adapted virus mutants (used as potential vaccines) that have the capacity to elicit conventional and unconventional T cell responses.

Original languageEnglish (US)
Pages (from-to)273-291
Number of pages19
JournalGeroScience
Volume39
Issue number3
DOIs
StatePublished - Jun 1 2017

Keywords

  • Aging
  • Cytomegalovirus
  • Immune evasion
  • Immune manipulation

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Fingerprint Dive into the research topics of 'CMV immune evasion and manipulation of the immune system with aging'. Together they form a unique fingerprint.

  • Cite this

    Jackson, S. E., Redeker, A., Arens, R., van Baarle, D., van den Berg, S. P. H., Benedict, C. A., Čičin-Šain, L., Hill, A. B., & Wills, M. R. (2017). CMV immune evasion and manipulation of the immune system with aging. GeroScience, 39(3), 273-291. https://doi.org/10.1007/s11357-017-9986-6